Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration.

چکیده

To compare early anatomic outcomes after treatment with faricimab versus aflibercept in a pooled analysis of the head-to-head dosing phase of the TENAYA/LUCERNE trials in neovascular age-related macular degeneration (nAMD). TENAYA/LUCERNE (NCT03823287/NCT03823300) were identical, randomized,…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط